Abstract:OBJECTIVE To evaluate the expression of EphA2 protein in tissue specimens and cell lines of laryngeal squamous cell carcinoma (LSCC), and to further study the correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in LSCC. METHODS Western blot was applied to assess the EphA2 protein expression in LSCC cell line Hep-2 cells and the head and neck immortalized epithelial cell line NP-69 cells. Immunohistochemical staining was performed on paraffin sections of 88 cases of LSCC specimens and 16 cases of adjcent normal tissue samples to investigate the EphA2 protein expression, and to futher elucidate its correlation with clinicopathological characteristics. RESULTS Compared with the NP-69 cells, EphA2 expression in LSCC cell line Hep-2 cells was upregulated. The positive rates of EphA2 expression in LSCC and adjcent normal tissues samples were 80.7% and 43.8%, respectively, with a significant difference between the two groups (P < 0.001). EphA2 overexpresion was closely correlated with clinical stage (I + II/III + IV, P = 0.005), metastasis (P = 0.025) and recurrence (P = 0.021) in LSCC. Furthermore, patients with EphA2 overexpression had poorer tumor-free survival and 5-year overall survival compared with that in patients with low EphA2 expression (33.3% vs. 63.2%, P = 0.003; 46.7% vs. 81.6%, P = 0.002). EphA2 expression combined with clinical stage provided a better predictive value in prognosis. Univariate and multivariate Cox regression analysis revealed that EphA2 expression is an independent prognostic factor for patients with LSCC (P = 0.019). CONCLUSIONS The results of this study demonstrate that EphA2 protein expression is significantly increased in LSCC tissues and cell lines, and EphA2 protein overexpression is associated with tumor recurrence, metastasis and poorer prognosis in LSCC patients. These results suggest that EphA2 may play a critical role in the initiation and progression of LSCC, implicating EphA2 as a valuable marker for the prediction of recurrence, metastasis and prognosis in LSCC.

The Expression and Significance of EphB2, EphrinB2 and EphrinA1 in Laryngeal Carcinoma Tissues

[Expression of Vascular Endothelial Growth Factor and Its Receptors in Laryngeal Carcinoma Cell and Its Significance].

Expression of EphB4 and HIF-1α in Lung Cancer and Its Clinical Significance

Expression of EphB4 receptor and its ligand EphrinB2 in esophageal cancer tissues and their relationship with tumor angiogenesis

[Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].

Over-Expression of EphA2 and EphrinA-1 in Human Gastric Adenocarcinoma and Its Prognostic Value for Postoperative Patients

Clinical Significance of Ephrin A1 Expression in Cervical Carcinoma

The Expressions of EphB4 and Ephrinb2 in Lung Adenocarcinomas: a High Level of the EphB4 Protein is Associated with Lymph Node Metastasis.

EGFR, HER2, and HER3 Expression in Laryngeal Primary Tumors and Corresponding Metastases

Expressions of E-cadherin, Cath-D, and VEGF in Laryngeal Squamous Cell Carcinoma and Cervical Lymph Node Mtastatic

Expression of E-cadherin、Cath-D、VEGF and Their Significance in Metastasis of Laryngeal Squamous Cell Carcinoma

The relationship between the expression of EphA1 in gastric carcinoma, metastasis and survival

Significance Expression and Relationships with Endothelin-1,Matrix Metalloproteinase-9 in the Laryngeal Carcinoma

Mutation and Expression of EphB4 Gene in Human Laryngeal Squamous Cell Carcinoma

[The Relationship Between ECM1 and the Angiogenesis and Metastasis of Laryngeal Carcinoma].

Expression and clinical significance of EphA2 in hepatocellular carcinoma

High Expression of EphA4 is Associated with Invasion and Lymph Node Metastasis in Colorectal Carcinomas.

Expression of EphB2 in gastric carcinoma and the correlation with metastasis

Expression of LKB 1 and Vascular Endothelial Growth Factor-C in Human Laryngeal Cancer and Its Significance

Enhanced Expression Of Ephrinb1 Is Associated With Lymph Node Metastasis And Poor Prognosis In Breast Cancer

Expression of the EphA2 Gene in Esophageal Carcinoma Tissues